P&G stops selling Vicks
Action 500 Extra in India after ban
Send a link to a friend
[March 15, 2016]
MUMBAI (Reuters) - U.S. consumer
health giant Procter & Gamble's India unit said on Tuesday it had
stopped manufacture and sale of its cough-and-cold medicine Vicks Action
500 Extra with immediate effect, after regulators banned it citing
potential health risk.
|
The product is a fixed dose combination of paracetamol,
phenylephrine and caffeine, which was banned by India's health
ministry in a notice issued over the weekend, Procter & Gamble
Hygiene and Health Care Ltd informed the stock exchange.
The drug was one of 344 drug combinations including several
antibiotics and analgesics that India ordered to be prohibited
saying a government-appointed panel of experts had found the
combinations lacked "therapeutic justification."
P&G said all its products, including Vicks Action 500 Extra, were
backed by research to support their quality, safety and efficacy.
It wasn't immediately clear how much the product contributed to
P&G's sales.
(Reporting by Zeba Siddiqui in Mumbai; Editing by Gopakumar Warrier)
[© 2016 Thomson Reuters. All rights
reserved.] Copyright 2016 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
|
|